CAS RN: 926037-48-1
Radotinib
Product Availability
Choose a grade to view its available package options.
9 package records7 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20251011 |
5mg / 25mg / 100mg |
Out of stock |
| 8-10 business days | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260315 |
100mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250213 |
10mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20251104 |
1g |
In stock |
Shanghai | | Inquiry |
| Batchno.20250222 |
1mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20251109 |
250mg |
Out of stock |
| | Inquiry |
| Batchno.20250521 |
25mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20251123 |
50mg |
In stock |
Shanghai, Shenzhen, Tianjin | | Inquiry |
| Batchno.20260228 |
5mg |
In stock |
Shanghai | | Inquiry |
-
Product code:
starshine_CAS926037-48-1
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
926037-48-1 / 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyrazin-2-ylpyrimidin-2-yl)amino]benzamide
Standard CAS: 926037-48-1
Multi CAS: Yes
Basic Information
CAS
926037-48-1
Multi CAS
Yes
Molecular Formula
C27F3H21N8O
Molecular Weight
530.500000
Exact Mass
530.179042
InChI
InChI=1S/C27H21F3N8O/c1-16-3-4-18(9-23(16)37-26-33-6-5-22(36-26)24-13-31-7-8-32-24)25(39)35-20-10-19(27(28,29)30)11-21(12-20)38-14-17(2)34-15-38/h3-15H,1-2H3,(H,35,39)(H,33,36,37)
InChIKey
DUPWHXBITIZIKZ-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
39
Aromatic heavy atom count
29
Fraction Csp3
0.11
Rotatable bonds
6
H-bond acceptors
8
H-bond donors
2
Molar refractivity
138.78
TPSA
110.51
LogP / Solubility
WLOGP
5.75
MLOGP
5.1
XLogP3
3.9
Consensus LogP
4.92
Log S (ESOL)
-6.91
Class (ESOL)
Insoluble
Log S (Ali)
-8.06
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-8.6
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.87
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.56
Leadlikeness
No
Synthetic Accessibility
5